Healthcare - Biotechnology - NASDAQ - US
$ 56.62
-6.18 %
$ 2.29 B
Market Cap
-10.85
P/E
INCOME STATEMENT
151 K
REVENUE
-170 M
OPERATING INCOME
-153 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Keros Therapeutics, Inc.
| Revenue | 151 K |
| Cost Of Revenue | 815 K |
| Gross Profit | -664 K |
| Operating Expenses | 169 M |
| Operating Income | -170 M |
| Other Expenses | -16.9 M |
| Net Income | -153 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0.2 | 0 | 20.1 | 0 | 10.0 | 10.0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 0.8 | 1.6 | 0.9 | 0.6 | 17.3 | 10.1 |
| Gross Profit | (0.7) | (1.6) | 19.2 | (0.6) | (7.3) | (0.1) |
| OPERATING INCOME | ||||||
| Operating Expenses | 169.3 | 107.7 | 76.5 | 44.2 | 20.0 | 11.3 |
| Selling, General and Administrative Expenses | 34.8 | 27.5 | 21.3 | 12.8 | 3.2 | 1.6 |
| Research and Development Expenses | 135.3 | 87.3 | 55.1 | 33.9 | 17.4 | 10.1 |
| Operating Income | (169.9) | (114.8) | (56.4) | (46.7) | (10.6) | (1.7) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 1 K | 4 K | 6 K | 8 K | 0 |
| Total Other Income | 16.9 | 10.1 | (0.4) | 1.1 | (1.8) | 0.6 |
| Pre-Tax Income | (153.0) | (104.7) | (56.7) | (45.5) | (12.3) | (1.1) |
| NET INCOME | ||||||
| Tax Provision | 0 | 1 K | 2.0 | (0.2) | 8 K | 0.3 |
| Net Income | (153.0) | (104.7) | (58.7) | (45.4) | (12.3) | (1.3) |
| EPS | 5.2 | 4.15 | 2.52 | 2.93 | 1.39 | 0.15 |